Do beta-lactam-beta-lactamase inhibitor combinations have a place in the treatment of multidrug-resistant pulmonary tuberculosis?

Tuber Lung Dis. 1995 Feb;76(1):90-2. doi: 10.1016/0962-8479(95)90588-x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Amoxicillin / therapeutic use
  • Anti-Bacterial Agents / therapeutic use*
  • Clavulanic Acids / therapeutic use
  • Drug Therapy, Combination / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Pulmonary / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Clavulanic Acids
  • Amoxicillin